Clinical Trial Update: MEDI7183 Phase 2 Study in Japanese Ulcerative Colitis Patients [Phase 2]

View source ↗

Summary

Phase 2 study of MEDI7183 in Japanese patients with ulcerative colitis completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• MEDI7183

Snippet

Sponsor: AstraZeneca | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED | Results posted: 2019-07-05